Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 146.47 USD -0.62% Market Closed
Market Cap: 21.3B USD
Have any thoughts about
Biogen Inc?
Write Note

Relative Value

The Relative Value of one BIIB stock under the Base Case scenario is 211.8 USD. Compared to the current market price of 146.47 USD, Biogen Inc is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIIB Relative Value
Base Case
211.8 USD
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
72
Median 3Y
3.4
Median 5Y
3.3
Industry
7.6
Forward
2.2
vs History
66
vs Industry
6
Median 3Y
19.9
Median 5Y
14.5
Industry
22.1
Forward
8.7
vs History
66
vs Industry
9
Median 3Y
18.1
Median 5Y
12
Industry
21.9
vs History
4
vs Industry
5
Median 3Y
29.2
Median 5Y
13.2
Industry
23.4
vs History
98
vs Industry
41
Median 3Y
2.6
Median 5Y
3.1
Industry
2.5
vs History
98
vs Industry
58
Median 3Y
3.8
Median 5Y
3.6
Industry
7.5
Forward
2.4
vs History
96
vs Industry
53
Median 3Y
5.1
Median 5Y
4.3
Industry
9.3
vs History
76
vs Industry
8
Median 3Y
11.6
Median 5Y
9.9
Industry
4.2
Forward
6.6
vs History
69
vs Industry
7
Median 3Y
13.5
Median 5Y
11.5
Industry
4
Forward
7.8
vs History
61
vs Industry
7
Median 3Y
19.7
Median 5Y
13.3
Industry
5.9
vs History
60
vs Industry
5
Median 3Y
23.9
Median 5Y
15.9
Industry
3.9
vs History
98
vs Industry
52
Median 3Y
1.7
Median 5Y
2.1
Industry
4.5

Multiples Across Competitors

BIIB Competitors Multiples
Biogen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Biogen Inc
NASDAQ:BIIB
21.2B USD 2.2 13.1 7.7 9.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4 33.5 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1 915.4 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6 -213.4 21 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6 16.6 15.1 16.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.4 -136.2 -110 -80.2
P/S Multiple
Revenue Growth P/S to Growth
US
Biogen Inc
NASDAQ:BIIB
Average P/S: 3 457 240.1
2.2
1%
2.2
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.4
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
US
Biogen Inc
NASDAQ:BIIB
Average P/E: 178.6
13.1
128%
0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Biogen Inc
NASDAQ:BIIB
Average EV/EBITDA: 15
7.7
43%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -110 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Biogen Inc
NASDAQ:BIIB
Average EV/EBIT: 19.6
9.7
49%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.2 N/A N/A

See Also

Discover More
Back to Top